Gary Goldenberg, Chief Medical Officer at Verrica Pharmaceuticals Inc. (VRCA), sold 13,489 shares at $2.46 ($35K) on 2024-08-27, disclosed to the SEC on 2024-08-28.
Open-market sale of $35k VRCA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.66 | 9,888 | $26K | 74.8% |
| 2 | $2.46 | 3,601 | $9K | 25.2% |
| Total | $2.61 avg | 13,489 | $35K | 100% |
| Filing → |
| VRCA | SELL | 2023-07-25 | $277K | — | Filing → |
| VRCA | BUY | 2022-07-05 | $50K | — | Filing → |